Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124682435 | 12468243 | 5 | F | 20160525 | 20160816 | 20160615 | 20160819 | PER | US-TAKEDA-2016MPI005303 | TAKEDA | 88.67 | YR | M | Y | 0.00000 | 20160819 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124682435 | 12468243 | 1 | PS | NINLARO | IXAZOMIB | 1 | Oral | 3 MG, UNK | U | 208462 | 3 | MG | CAPSULE | ||||||
| 124682435 | 12468243 | 2 | SS | NINLARO | IXAZOMIB | 1 | Oral | 4 MG, UNK | U | 208462 | 4 | MG | CAPSULE | ||||||
| 124682435 | 12468243 | 3 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | U | 0 | |||||||||
| 124682435 | 12468243 | 4 | C | REVLIMID | LENALIDOMIDE | 1 | 5 MG, UNK | U | 0 | 5 | MG | CAPSULE | |||||||
| 124682435 | 12468243 | 5 | C | ACYCLOVIR /00587301/ | ACYCLOVIR | 1 | U | 0 | |||||||||||
| 124682435 | 12468243 | 6 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | U | 0 | |||||||||||
| 124682435 | 12468243 | 7 | C | SULFAMETHOXAZOLE AND TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | U | 0 | |||||||||||
| 124682435 | 12468243 | 8 | C | PROMETHAZINE HCL | PROMETHAZINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 124682435 | 12468243 | 9 | C | ZOLPIDEM TARTATE | ZOLPIDEM TARTRATE | 1 | U | 0 | |||||||||||
| 124682435 | 12468243 | 10 | C | MECLIZINE HCL | MECLIZINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 124682435 | 12468243 | 11 | C | TAMSULOSIN HCL | TAMSULOSIN | 1 | U | 0 | |||||||||||
| 124682435 | 12468243 | 12 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | U | 0 | |||||||||||
| 124682435 | 12468243 | 13 | C | PANTOPRAZOLE SODIUM. | PANTOPRAZOLE SODIUM | 1 | U | 0 | |||||||||||
| 124682435 | 12468243 | 14 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | U | 0 | |||||||||||
| 124682435 | 12468243 | 15 | C | VITAMIN D2 | ERGOCALCIFEROL | 1 | U | 0 | |||||||||||
| 124682435 | 12468243 | 16 | C | TYLENOL | ACETAMINOPHEN | 1 | U | 0 | |||||||||||
| 124682435 | 12468243 | 17 | C | CALCIUM | CALCIUM | 1 | U | 0 | |||||||||||
| 124682435 | 12468243 | 18 | C | ZOMETA | ZOLEDRONIC ACID | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124682435 | 12468243 | 1 | Plasma cell myeloma |
| 124682435 | 12468243 | 3 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124682435 | 12468243 | Decreased appetite | |
| 124682435 | 12468243 | Diarrhoea | |
| 124682435 | 12468243 | Frequent bowel movements | |
| 124682435 | 12468243 | Full blood count decreased | |
| 124682435 | 12468243 | Gastrointestinal stoma complication | |
| 124682435 | 12468243 | Lethargy | |
| 124682435 | 12468243 | Liver function test increased | |
| 124682435 | 12468243 | Skin discolouration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124682435 | 12468243 | 1 | 20160518 | 0 |